Drug Trial Radar · NCT02157506
A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
Last checked: Nov 20, 2026Latest source record: Jul 31, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
Jun 30, 2014
Primary completion
May 31, 2015
Study completion Jul 31, 2015
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- Collaborators
- Cardioxyl Pharmaceuticals, Inc
- First posted
- Jun 6, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized, double-blinded, placebo-controlled study of continuous 6-hour IV infusions of CXL-1427 in hospitalized patients with systolic heart failure.
Conditions
- Heart Failure
- Decompensated Heart Failure
- Acute Heart Failure
Interventions
CXL-1427Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse EventsTime frame: 30 days following the initiation of treatment
- Mean Time Averaged Change From Baseline in Adjudicated Pulmonary Capillary Wedge Pressure (PCWP) During InfusionTime frame: Baseline, Hour 2, Hour 4, Hour 6, Hour 8 post infusion
- Mean Time-Averaged Change From Baseline in Adjudicated Pulmonary Artery Diastolic Pressure (PAD) During the InfusionTime frame: Baseline, Hour 2, Hour 4, Hour 6, Hour 8 post infusion initiation
- Mean Time-Averaged Percent Change From Baseline in Cardiac Index (Fick)Time frame: Baseline, Hour 2, Hour 4, Hour 6, Hour 8 post infusion initiation
Locations
35 sites in 5 countries. Site status is shown where the registry gives one.
Cardioxyl Study Site
Gainesville, Florida
Cardioxyl Study Site
Jacksonville, Florida
Cardioxyl Study Site
Jacksonville, Florida
Cardioxyl Study Site
Macon, Georgia
Cardioxyl Study Site
Baltimore, Maryland
Cardioxyl Study Site
Detroit, Michigan
Cardioxyl Study Site
Newark, New Jersey
Cardioxyl Study Site
Chapel Hill, North Carolina
Cardioxyl Study Site
Cincinnati, Ohio
Cardioxyl Study Site
Columbus, Ohio
Cardioxyl Study Site
Charleston, South Carolina
Cardioxyl Study Site
Nashville, Tennessee
Cardioxyl Study Site
Salt Lake City, Utah
Cardioxyl Study Site
Richmond, Virginia
Cardioxyl Study Site
Bad Neuheim, Germany
Cardioxyl Study Site
Cologne, Germany
Cardioxyl Study Site
Frankfurt, Germany
Cardioxyl Study Site
Göttingen, Germany
Cardioxyl Study Site
Greifswald, Germany
Cardioxyl Study Site
Kiel, Germany
Cardioxyl Study Site
Regensberg, Germany
Cardioxyl Study Site
Amman, Jordan
Cardioxyl Study Site
Irbid, Jordan
Cardioxyl Study Site
Lodz, Poland
Cardioxyl Study SIte
Warsaw, Poland
Cardioxyl Study Site
Warsaw, Poland
Cardioxyl Study Site
Wroclaw, Poland
Cardioxyl Study Site
Kemerovo, Russia
Cardioxyl Study Site
Moscow, Russia
Cardioxyl Study Site
Moscow, Russia
Cardioxyl Study Site
Moscow, Russia
Cardioxyl Study Site
Moscow, Russia
Cardioxyl Study Site
Saint Petersburg, Russia
Cardioxyl Study Site
Saint Petersburg, Russia
Cardioxyl Study Site
Tomsk, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.